UA104126C2 - Профилактическая вакцина от туберкулеза - Google Patents

Профилактическая вакцина от туберкулеза

Info

Publication number
UA104126C2
UA104126C2 UAA200905336A UAA200905336A UA104126C2 UA 104126 C2 UA104126 C2 UA 104126C2 UA A200905336 A UAA200905336 A UA A200905336A UA A200905336 A UAA200905336 A UA A200905336A UA 104126 C2 UA104126 C2 UA 104126C2
Authority
UA
Ukraine
Prior art keywords
mtb
tuberculosis vaccine
virulent
prophylactic
strain
Prior art date
Application number
UAA200905336A
Other languages
English (en)
Ukrainian (uk)
Inventor
ИГЛЕСИАС Пере Хоан КАРДОНА
РЬЕРА Исабель АМАТ
Original Assignee
Арчивель Фарма, Сл
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Арчивель Фарма, Сл filed Critical Арчивель Фарма, Сл
Publication of UA104126C2 publication Critical patent/UA104126C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Изобретение относится к применению иммунотерапевтического средства, которое содержит фрагменты клеточной стенки комплекса(MTB-C), для получения лекарственного средства для профилактического лечения туберкулеза, в котором указанное средство получено с использованием способа, который включает культивирование вирулентного штамма МТВ-С на протяжении периода, который равняется или превышает три недели, с последующей гомогенизацией культуры клеток в присутствии неионного поверхностно-активного вещества.
UAA200905336A 2006-10-30 2007-10-17 Профилактическая вакцина от туберкулеза UA104126C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200602754A ES2307402B1 (es) 2006-10-30 2006-10-30 Vacuna profilactica contra la tuberculosis.
PCT/ES2007/000583 WO2008053055A1 (es) 2006-10-30 2007-10-17 Vacuna profiláctica contra la tuberculosis

Publications (1)

Publication Number Publication Date
UA104126C2 true UA104126C2 (ru) 2014-01-10

Family

ID=39343853

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200905336A UA104126C2 (ru) 2006-10-30 2007-10-17 Профилактическая вакцина от туберкулеза

Country Status (20)

Country Link
US (1) US9289483B2 (ru)
EP (1) EP2090318B1 (ru)
JP (1) JP2010508254A (ru)
KR (1) KR20090087874A (ru)
CN (1) CN101600455B (ru)
AU (1) AU2007316091B2 (ru)
BR (1) BRPI0715297B8 (ru)
CA (1) CA2667965C (ru)
DK (1) DK2090318T3 (ru)
ES (2) ES2307402B1 (ru)
HK (1) HK1138786A1 (ru)
IL (1) IL198357A (ru)
MX (1) MX2009004258A (ru)
NZ (1) NZ576489A (ru)
PL (1) PL2090318T3 (ru)
PT (1) PT2090318E (ru)
RU (1) RU2526910C2 (ru)
UA (1) UA104126C2 (ru)
WO (1) WO2008053055A1 (ru)
ZA (1) ZA200902937B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2335177B1 (es) 2008-09-19 2011-02-28 Archivel Farma, S.L. Agente inmunoterapeutico apropiado para la profilaxis primaria de la tuberculosis.
ES2744541T3 (es) 2008-12-08 2020-02-25 Gilead Connecticut Inc Inhibidores de imidazopirazina Syk
SI2716157T1 (sl) 2008-12-08 2016-10-28 Gilead Connecticut, Inc., c/o Gilead Sciences, Inc. Imidazopirazinski Syk-inhibitorji
EP2471511A1 (en) 2011-01-04 2012-07-04 Archivel Farma, SL Liposome formulation suitable for treating or preventing tuberculosis
SI2661253T1 (sl) * 2011-01-04 2017-07-31 Archivel Farma, Sl Liposomska formulacija, ustrezna za zdravljenje ali preprečevanje tuberkuloze
BR112014017217B1 (pt) 2012-01-12 2023-01-17 Archivel Farma, S.L Agente e composição farmacêutica
EP3927708A1 (en) 2019-02-22 2021-12-29 Kronos Bio, Inc. Solid forms of condensed pyrazines as syk inhibitors
WO2023062066A1 (en) 2021-10-14 2023-04-20 Archivel Farma, S.L. Liposome formulations for treatment of active tuberculosis

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641814B1 (en) 1997-04-02 2003-11-04 Statens Serum Institut Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis
RU2093046C1 (ru) * 1996-05-06 1997-10-20 Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН Лечебно-профилактическая пищевая композиция "гербамарин"
US6284255B1 (en) 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
DE69839782D1 (de) * 1997-03-03 2008-09-04 Adcock Ingram Ltd Eine Zusammensetzung, die eine Trägerkomponente und eine gereinigte mykobakterielle Zellwandkomponente enthält, und ihre Verwendung zur Verhinderung, Behandlung und Diagnose von Erkrankungen
US7037510B2 (en) * 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
EP1117683A2 (en) 1998-10-08 2001-07-25 Statens Serum Institut Tb vaccine and diagnostic based on antigens from the m. tuberculosis cell
RU2153354C1 (ru) * 1999-03-31 2000-07-27 Московский городской научно-практический центр борьбы с туберкулезом Вакцина против туберкулеза
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
EP1351699A4 (en) * 2000-12-08 2006-07-05 Ying Dr Zhang METHOD FOR IMPROVED DIAGNOSIS AND TREATMENT OF MYCOBACTERIAL INFECTIONS
EP2196473A1 (en) 2001-07-04 2010-06-16 Health Protection Agency Mycobacterial antigens expressed during latency
CN1694725A (zh) * 2001-08-02 2005-11-09 纽约大学 肽在早期检测分枝杆菌疾病中的应用
WO2003018053A1 (en) 2001-08-22 2003-03-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Vaccine against mycobacterial-induced diseases
BR0307262A (pt) * 2002-01-29 2006-12-19 Bakulesh Mafatlal Khamar método de prover profilaxia para tuberculose em indivìduos hiv positivos
CN1467221A (zh) * 2002-07-14 2004-01-14 虹 王 结核杆菌cfp-10、esat-6与cd40l融合疫苗的制备及应用
ES2231037B1 (es) * 2003-10-31 2005-12-16 Archivel Technologies, Sl Agente inmunoterapico util para el tratamiento combinado de la tuberculosis en asociacion con otros farmacos.
ES2335177B1 (es) * 2008-09-19 2011-02-28 Archivel Farma, S.L. Agente inmunoterapeutico apropiado para la profilaxis primaria de la tuberculosis.

Also Published As

Publication number Publication date
PT2090318E (pt) 2012-11-14
ES2307402B1 (es) 2009-09-30
EP2090318A1 (en) 2009-08-19
AU2007316091A1 (en) 2008-05-08
RU2009120522A (ru) 2013-01-20
CN101600455B (zh) 2013-08-07
JP2010508254A (ja) 2010-03-18
US20100068258A1 (en) 2010-03-18
CA2667965C (en) 2016-08-23
ZA200902937B (en) 2010-02-24
WO2008053055A1 (es) 2008-05-08
BRPI0715297B8 (pt) 2021-05-25
DK2090318T3 (da) 2012-11-19
MX2009004258A (es) 2009-05-11
PL2090318T3 (pl) 2013-03-29
EP2090318B1 (en) 2012-08-08
IL198357A (en) 2013-03-24
BRPI0715297A2 (pt) 2015-02-03
IL198357A0 (en) 2011-08-01
CN101600455A (zh) 2009-12-09
CA2667965A1 (en) 2008-08-05
NZ576489A (en) 2012-02-24
RU2526910C2 (ru) 2014-08-27
AU2007316091B2 (en) 2013-06-27
US9289483B2 (en) 2016-03-22
EP2090318A4 (en) 2010-01-27
ES2393007T3 (es) 2012-12-17
BRPI0715297B1 (pt) 2019-01-29
HK1138786A1 (en) 2010-09-03
KR20090087874A (ko) 2009-08-18
ES2307402A1 (es) 2008-11-16

Similar Documents

Publication Publication Date Title
UA104126C2 (ru) Профилактическая вакцина от туберкулеза
WO2010019262A3 (en) Polyvalent vaccine
WO2007024941A3 (en) Polyvalent vaccine
IN2012DN01898A (ru)
MX2010005642A (es) Preparados, metodos y estuches para el tratamiento de la tos.
WO2008039874A3 (en) Cancer stem cell antigen vaccines and methods
MX2012005863A (es) Formulaciones de anticuerpos.
NZ616304A (en) Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
PH12014501836A1 (en) Novel adjuvant compositions
EP2588592A4 (en) USE OF PERFUSION DECELLULARIZED ORGANS FOR AGGREGATE RECELLULARIZATION
MA32819B1 (fr) Vaccin combine notamment contre la coqueluche acellulaire
CA2763359C (en) New human rotavirus strains and vaccines
EP1869225A4 (en) METAPNEUMOVIRENSTÄMME AND THEIR USE IN VACCINATE FORMULATIONS AND AS VECTORS FOR THE EXPRESSION OF ANTIGENOUS SEQUENCES AND METHOD FOR SPREADING THE VIRUS
CL2011000913A1 (es) Vacuna combinada estable y completamente liquida que comprende antigenos difterico, tetanico, pertusico de celulas completas, y virus de poliomielitis y opcionalmente uno o mas antigenos seleccionados entre haemophilus influenzae y hepatitis; y proceso de fabricacion.
WO2008048344A3 (en) Bacillus anthracis antigens, vaccine compositions, and related methods
WO2012065135A3 (en) Immunomodulatory compositions, methods and systems comprising immunogenic fragments of apob100
AU2007272785A8 (en) Methods to elicit, enhance and sustain immune responses against MHC class-I restricted epitopes, for prophylactic or therapeutic purposes
NZ589981A (en) Cattle vaccines comprising a disrupted M. bovis bacterium
EP2597151A4 (en) RECOMBINANT MICROORGANISMS, METHODS FOR THE PREPARATION OF VACCINE STRAINS, ANTIGENS, VECTORIZED VACCINE COMPOSITIONS, USES THEREOF, ANTIBODIES, DIAGNOSTIC KIT AND METHODS OF TREATMENT AND / OR PROPHYLAXIS
BR112013001168A2 (pt) "toxóide, composição farmacêutica, método de produzir uma antitoxina, antitoxina, e, métodos de tratar um indivíduo intoxicado de vacinação contra a intoxicação por uma toxina e de tratar um mamífero intoxicado."
DE60336588D1 (de) Verbesserte anthraximpfstoffe und abgabeverfahren
GB2452892A (en) Process for culturing bacteria of the piscirickettsia genus
WO2010006326A3 (en) Methods and compositions for spore-based vaccines
NZ607792A (en) Improved vaccine compositions
MX337070B (es) Método para preparar un conjugado klh-egfrviii.